Highly Stable Silver(I) Complexes with Cyclen-Based Ligands Bearing Sulfide Arms: A Step Toward Silver-111 Labeled Radiopharmaceuticals Article Swipe
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1021/acs.inorgchem.0c01405
· OA: W3041106002
With a half-life of 7.45 days, silver-111 (β<sub>max</sub> 1.04 MeV, <i>E</i><sub>γ</sub> 245.4 keV [<i>I</i><sub>γ</sub> 1.24%], <i>E</i><sub>γ</sub> 342.1 keV [<i>I</i><sub>γ</sub> 6.7%]) is a promising candidate for targeted cancer therapy with <i>β</i><sup><i>-</i></sup> emitters as well as for associated SPECT imaging. For its clinical use, the development of suitable ligands that form sufficiently stable Ag<sup>+</sup>-complexes <i>in vivo</i> is required. In this work, the following sulfur-containing derivatives of tetraazacyclododecane (cyclen) have been considered as potential chelators for silver-111: 1,4,7,10-tetrakis(2-(methylsulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane (DO4S), (2S,5S,8S,11S)-2,5,8,11-tetramethyl-1,4,7,10-tetrakis(2-(methylsulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane (DO4S4Me), 1,4,7-tris(2-(methylsulfanyl)ethyl)-1,4,7,10-tetraazacyclododecane (DO3S), 1,4,7-tris(2-(methylsulfanyl)ethyl)-10-acetamido-1,4,7,10-tetraazacyclododecane (DO3SAm), and 1,7-bis(2-(methylsulfanyl)ethyl)-4,10,diacetic acid-1,4,7,10-tetraazacyclododecane (DO2A2S). Natural Ag<sup>+</sup> was used in pH/Ag-potentiometric and UV-vis spectrophotometric studies to determine the metal speciation existing in aqueous NaNO<sub>3</sub> 0.15 M at 25 °C and the equilibrium constants of the complexes, whereas NMR and DFT calculations gave structural insights. Overall results indicated that sulfide pendant arms coordinate Ag<sup>+</sup> allowing the formation of very stable complexes, both at acidic and physiological pH. Furthermore, radiolabeling, stability in saline phosphate buffer, and metal-competition experiments using the two ligands forming the strongest complexes, DO4S and DO4S4Me, were carried out with [<sup>111</sup>Ag]Ag<sup>+</sup> and promising results were obtained.